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I N T R O D U C T I O N
The central nervous system (CNS), the brain and spinal cord, begins to develop very early in human embryonic life. During the 3rd week after conception the neural plate appears down the midline of the embryo's back, and ridges of this tissue, the neural folds, rise up each side of the midline from head to tail. Starting approximately where the brain and spinal cord will join, the apices of these folds fuse in the midline to form the neural tube. The tube is completed by closure of the top and bottom ends late in the 4th week of embryonic life. If the head end fails to close, the cerebral hemispheres and cranial vault do not develop. This defect is called anencephalus (anencephaly) and is incompatible with life. If the tail end of the neural tube is not completed normally, the lower part of the neural plate remains exposed. This defect is myelomeningocele, a form of spina bifida, which commonly results in paralysis and loss of sensation of the lower half of the body.
Neural tube defects (NTD) are largely made up of anencephalus and spina bifida. For the purposes of the present review NTD also includes meningocele (which does not affect neural tissue) and encephalocele (which may or may not involve the brain), but not spina bifida occulta (which does not normally involve neural tissue) or isolated hydrocephalus.
Although the birth prevalence of NTD has been decreasing for some 20 years in the United Kingdom (and for longer in some other countries), they are still amongst the most common major malformations, affecting 1-5/ 1000 babies and a substantial number of spontaneously aborted fetuses.
A very small number of NTD have a purely genetic basis (e.g. encephalocele in Meckel's syndrome, an autosomal recessive disorder), but epidemiological and other studies indicate that the great majority result from an interaction between genetic and environmental factors. Genetic influences are suggested by the racial differences in NTD rates which are only partially affected by migration (Stevenson et al. 1966; Naggan & MacMahon, 1967; Leck, 1969) . For example, rates are high in the Irish, low in blacks; high in Sikhs, low in other Indian ethnic groups. Concordance for NTD is higher in monozygotic (identical) than in dizygotic twins, but in identical twins it is far below the 100 YO expected for a purely genetic disorder.
The relevance of non-genetic factors is indicated by the rapidity of secular changes in NTD rate (Leck, 1983) , which cannot be explained on any genetic basis; the social class and geographic differences (higher rates among the less privileged, especially marked in areas of high prevalence (Leck et al. 1968; Fedrick, 1970; Wilson, 1970; Carter & Evans, 1973; Elwood & Nevin, 1973) ; the increased NTD frequency in pregnancies immediately following miscarriage (Smithells & Chinn, 1965; Clarke et al. 1975) ; and the apparent preventive effect of vitamin supplementation which is here reviewed.
A variety of environmental factors which might explain the social class and geographic differences have been considered, including infection (Record, 1961) , soft water (Stocks, 1970) and the consumption of blighted potatoes (Renwick, 1972) . Poor nutrition also correlates broadly with the geographic and social class distribution of NTD in Britain (Smithells et al. 1976 (Smithells et al. , 1977 Hurley, 1981 ; Rogozinski et aE. 1983; Hall, 1986; Whichelow & Erzinglioglu, 1990) , although rates are relatively low in the Third World areas of protein-energy malnutrition. The association between poor nutrition and NTD has proved to be one of the most persistent features of the condition, and it applies less strikingly or not at all to other birth defects. For example, babies conceived at the height of the Dutch hunger winter towards the end of the 1939-1945 war had a higher NTD rate than those conceived before or after, but other defect rates were not increased (Stein et al. 1975) .
N U T R I T I 0 N A L DEFICIENCY A N D NTD A N I M A L S T U D I E S
Attempting to identify the particular nutrients which may be implicated is difficult. Animal studies which allow controlled manipulation of specific nutrients may be helpful, but there are problems with this approach. There are huge inter-species differences in susceptibility to congenital malformations induced by dietary manipulations, with differences found even between different strains of a single species (Seller, 1983 a) . Also much animal experimental work has involved the induction of severe deficiency states which are scarcely ever applicable to man.
There are a number of reports indicating the excessive administration of vitamin A or its metabolites can produce NTD (Cohlan, 1954; Marin-Padilla & Ferm, 1965; Palludan, 1966; Seller, 1983~) . In contrast, deficiencies of vitamins E, B,, B,, and pantothenic acid have been implicated in a variety of CNS malformations including NTD (LefebvresBoisselot, 1951; Cheng et al. 1960; Woodard & Newberne, 1966; Curley et al. 1968; Davis er al. 1970 ). Nelson (1957) reported that anti-metabolites of folic acid administered at a critical point in embryogenesis appear to be highly teratogenic to the CNS. An apparent protective effect of folic acid has been found, its administration reducing the spontaneous NTD rate (Moffa & White, 1983) and experimental CNS malformations induced by anti-convulsant drugs (Trotz et al. 1985; Zhu & Zhou, 1989 ) and the antimalarial pyrimethamine (Horvath et al. 1988) . Zinc deficiency induces CNS malformations including NTD in the rat (Hurley & Swenerton, 1966; Rogers et al. 1985) . There could be a link here with folic acid because both micronutrients are found in similar foods, are associated in plasma (Cherry et al. 1981) and are linked metabolically (Tamura et al. 1978 (Tamura et al. , 1987 Canton et al. 1989) . Combined deficiencies of Zn and folk acid have been found to potentiate teratogenesis in the rat (Bremert et al. 1989) .
Although experimental teratogenesis in animals can only provide limited help to our understanding of the causation of NTD in man, it has pointed to a role of micronutrients, particularly vitamin A, folic acid and Zn.
S T U D I E S I N M A N
In man the association found in the general population between undernutrition and the prelevance of NTD (Smithells et al. 1976 (Smithells et al. , 1977 Hurley, 1977 Hurley, , 1981 Soltan & Jenkins, 1982; Rogozinski et al. 1983; Al-Awadi et al. 1984; Hall, 1986; Whichelow & Erzinglioglu, 1990 ) has been investigated further through studies of NTD affected pregnancies or women who have had such pregnancies and are, therefore, at increased risk of recurrence. Laurence et al.
(1 983) reported NTD recurrence only in infants born to women who had a poor diet, but most studies have focussed on specific micronutrients. Both vitamin C (Smithells et al. 1976; Schorah et al. 1983) and Zn deficiencies (Soltan & Jenkins, 1982) have been implicated. Low maternal serum vitamin B,, levels have been found early in NTD-affected pregnancies , but this has not been confirmed in a larger study (Molloy et al. 1985) . However, increased prevalence of NTD has been reported in women following gastric bypass surgery (Haddow et al. 1986 ) and these women often have low blood vitamin B,, and folic acid concentrations unless supplemented (Amaral et al. 1985) . The gastric connection is strengthened by the simultaneous fall worldwide in the prevalence of both gastric cancer and NTD and the recent discovery of familial clustering of the two conditions (Janerich et al. 1990 ). Folic acid, vitamin B,, and ascorbic acid can all be implicated in this link because poor intakes of fresh fruit and vegetables have been associated with both conditions, and intrinsic factor and vitamin C are secreted in gastric juice and this secretion is impaired by chronic atrophic gastritis which seems to be a prerequisite for the development of gastric cancer (Sobala et al. 1989) . The relevance of the relationship between folic acid and vitamin B,, will be considered in more detail in the section on micronutrient metabolism and NTD ; here we consider the increasing evidence for folate deficiency in the aetiology of NTD.
Evidence of disturbed folate metabolism at the end of pregnancies associated with NTD has been found by Hibbard & Smithells (1965) . However, because NTD arises during the 4th week of embryonic life it is necessary to assess potentially causal environmental factors as close to this time as possible rather than at term. In a large prospective study of vitamin nutrition in early pregnancy, Smithells et al. (1976) reported that women who were subsequently found to have had a fetus with NTD had significantly lower levels of erythrocyte (but not serum) folic acid, and leucocyte vitamin C than the rest of the population (Table 1) . Poor folate intake in early pregnancy, but not other nutrients, has been independently associated with NTD in a case-control study (Bower & Stanley, 1989) . Very recently, folate deficiency following post-hurricane-nutritional scarcity, has been associated with a threefold rise in the incidence of NTD (Duff et al. 1991) .
Indirect evidence linking folic acid metabolism with NTD comes from the observation that the folate antagonist aminopterin, when used as an abortifacient, caused malformations including those of the neural tube (Thiersch, 1952) . Interference with folate metabolism could also explain the link between anti-convulsant therapy in early pregnancy and congenital malformations including NTD (Bruckner et al. 1983; Strickler et al. 1985; Lindhout & Schmidt, 1986; Anon, 1988) . Anti-convulsant drugs have been shown to lower blood folic acid concentrations, possibly by decreasing folate absorption (Engelsen et al. 1984; Hendel et al. 1984; Dansky et al. 1987) . In an uncontrolled study Biale & Lowenthal (1984) have reported a reduction in all malformations in the offspring of women on anticonvulsants who were given folic acid supplements through early pregnancy.
There is, therefore, ample evidence of an association between poor nutrition, particularly folate deficiency, and NTD, but it is insufficient to determine if the relationship is causal. We, therefore, undertook an intervention study to see if multi-vitamin supplements would reduce the recurrence rate of NTD in high risk women. It was hoped that this approach would better examine the role of micronutrient deficiency in the aetiology of human NTD.
P E R I C O N C E P T I O N A L V I T A M I N I N T A K E A N D NTD M U L T I-VIT A M I N I N T E R V E N T I O N S T U D 1 E S
The details of these studies have been published (Smithells et al. , 1981 . Here only the essential features will be outlined, but the problems of interpreting the results will be considered in more detail.
Women who have previously had an infant or fetus with NTD have an approximately 1 0-fold higher risk of recurrence than the general NTD rate in the population. The risk is higher if they have had more than one affected infant. To minimize the number of women required in the study, we, therefore, recruited for vitamin supplementation only those who had had at least one affected child. We felt such women would also be well motivated to comply with the study protocol. Supplements were to be started before conception, so women already known to be pregnant were excluded. Ethical approval could not be obtained for a randomized, placebo-controlled trial, so we supplemented all women recruited. The preparation used (Pregnavite Forte F ; Bencard Ltd) provides approximately the recommended daily intakes of most vitamins (including folic acid but not vitamin B,,), iron and calcium (but not Zn), for the 2nd and 3rd trimesters of pregnancy. Volunteers were asked to take the supplement for not less than 28 d before conception and to continue until they had missed two menstrual periods (i.e. well after the time of neural tube closure). Women who conceived less than 28 d after starting supplements, who started supplements after conception but before closure of the neural tube, or who missed their tablets on more than 1 d, were classified as partially supplemented, the rest as fully supplemented. Women who proved to be pregnant when referred to the study centres (but who otherwise met the * Assumes 4 % recurrence rate after one previous NTD, 10% after two previous NTD (Seller & Nevin, 1984) .
criteria for admission to the study) were classified as unsupplemented, and their pregnancy outcomes compared with those of supplemented women. Table 2 shows the results of the intervention study. The difference between the recurrence rates in the supplemented and unsupplemented pregnancies is striking, indicating a 7-fold reduction in rate in those who were supplemented. Since the findings in Table 2 were published the study has continued, but because an increasing proportion of mothers at recurrence risk were recruited for supplementation there is no unsupplemented group in the more recent data. Our overall experience shows fourteen NTD recurrences from 1107 fully supplemented pregnancies. This is about 25% of the expected rate estimated from contemporary population recurrence values in the regions where the trials have been undertaken, but before they made a significant impact on overall recurrence rates (Seller & Nevin, 1984) .
Two supplementation studies have been carried out using folic acid only. Laurence et al. (1983) , in a randomized study, showed an apparent protective effect against NTD recurrence, but only after assuming that mothers with serum folate levels below a certain value (27 YO of the total) had been non-compliant, and combining them with the placebo group. A rather small, non-randomized study in Cuba (Verge1 et al. 1990) showed NTD recurrence rates of 3.5% and 0 % in unsupplemented and supplemented groups respectively, but this difference did not reach conventional levels of significance.
Because our own study was not randomized, the possibility must be considered that some unrecognized difference between the supplemented and unsupplemented mothers, which was present before they entered the study, could have accounted for the difference in recurrence rate: that is to say, the selection process led to a group of women at low risk of recurrence being chosen for supplementation (Knox, 1983; Oakley et al. 1983; Elwood, 1983; Wald & Polani, 1984) . A number of factors are known to be associated with NTD birth prevalence, and these could be associated with, and, therefore, perhaps modify, risk of recurrence, although this has not been demonstrated (Smithells & Chinn, 1965; Carter & Roberts, 1967; Clarke et al. 1975; Nevin et al. 1981) . The most significant of these are:
1. geographic and ethnic (e.g. high rates among the Irish, low rates among negroes, 2. secular (birth prevalence in the UK has fallen steadily since about 1972); t Values greater than unity indicate increased risk of NTD in the unsupplemented group compared with the supplemented group due to the factor, those less than one, the reverse.
5. some studies suggest that a shorter inter-pregnancy interval (fallow period) increases 6. a previous NTD increases the risk about 10-fold, and the risk increases with
We have analysed the data from our supplementation study in relation to these potential recurrence risk factors (Wild et al. 1986 ) and have found no significant difference between the supplemented and unsupplemented groups (Table 3) . Indeed, the only factor other than periconceptional vitamin supplementation found to affect recurrence rates significantly was two or more previous NTD, and this risk was distributed similarly in the two groups. Geographical and secular variations were not relevant because unsupplemented mothers came from the same areas over the same time-period as the supplemented. Although this analysis cannot rule out the possibility that some unknown factor with a major impact on recurrence was unevenly distributed between the two groups, this seems unlikely a priori, and such a factor is also likely to have an association with the known risk factors listed previously and, hence, be indirectly revealed by the foregoing analysis.
The possibility of some unknown bias can be looked for in an entirely different way. In two of the participating regions, Yorkshire and Northern Ireland, attempts have been made to supplement all women at risk of recurrence, and to determine the outcome of all such pregnancies, whether supplemented or not (Seller & Nevin, 1984; Smithells et al. 1989; (Seller & Nevin, 1984) .
by change in approach to ascertainment. Recurrence rates were not calculated until the cohorts were closed.
4). Recurrence rates have remained constant in both groups, with a 7-fold lower rate in the supplemented group. The overall recurrence rate has decreased as the proportion of women supplemented has increased, at a rate unlikely to be the result of a simple secular trend. Indeed, there is no evidence that the secular fall in NTD prevalence (Leck, 1983) has been followed by any major change in the recurrence rate, and certainly not of the order of the decrease seen in Yorkshire and Northern Ireland (Seller & Hancock, 1985; Czeizel, 1988) . Is it possible that some feature of the study other than the vitamin supplement has been responsible for the results? Two possibilities deserve consideration. In some participating centres, women were asked to avoid oral contraceptives (OC) for at least 28 d before conception because of the recognized ability of OC to depress the plasma levels of some vitamins. However, there is no good evidence linking OC with NTD or any other malformation, even when taken in early pregnancy.
The pregnancies of supplemented mothers were planned, and this would not be true of many unsupplemented pregnancies. Might the efficiency of pregnancy planning reflect some other factor relevant to NTD recurrence? Some of the partially supplemented mothers in our study were already in the early days of pregnancy when we first met them, but had not yet reached the dead-line for neural tube closure and they were, therefore, started on supplements. NTD recurrence in this group was very low, yet their pregnancies were largely unplanned . Conversely, when the potato blight hypothesis of Renwick (1972) was tested by potato avoidance trials (Nevin & Merrett, 1975) , similar pregnancy planning was required but NTD recurrence rates were unaffected.
Finally, vitamin supplements did not have a pseudo-protective effect by inducing spontaneous abortion of affected fetuses (Creasy & Alberman, 1976; MacHenry et al. 1979) . The proportion of pregnancies ending in spontaneous abortion was comparable in the two groups (supplemented 10.7 ' / o : unsupplemented 8-1 YO), and of the forty-three spontaneously aborted fetuses it was possible to examine, only one had NTD.
In conclusion, critical analysis of the multi-vitamin intervention studies for effects of bias introduced by non-randomization of volunteers into supplemented and unsupplemented groups has found none. The most straightforward interpretation of the findings remains Decreased risk associated with periconceptional vitamin use was significant: * P < 0.1, ** P < 005 that periconceptional multi-vitamin supplements have caused a significant decrease in the recurrence of NTD.
c. J. S C H O R A H A N D R. w. S M I T H E L L S
R E T R O S P E C T I V E S T U D I E S O F V I T A M I N I N T A K E
The findings of the multi-vitamin trial have prompted a number of researchers to investigate retrospectively the relationship between the prevalence of NTD and periconceptional vitamin supplementation. Four case-control studies have been reported and the results are summarized in Table 5 . There are two inherent problems in such studies. Women are asked to recall their vitamin intake in early pregnancy, sometimes after a period of several years. This introduces recall bias, because apart from the difficulty of accurate recall, there is also sometimes a desire to find reasons for an adverse outcome to pregnancy which could encourage denial of vitamin use. In addition, pregnancy outcome was analysed in terms of the mothers' periconceptional vitamin use, and it is possible that women who choose to take supplements early in pregnancy are different in ways which could, independently of vitamin use, reduce their risk of NTD (analysis bias).
In the study of Winship et al. (1984) , recall bias was minimized by the use of general practitioner records, but the numbers in the study were small. It is interesting to note that the evidence suggests that whilst folk acid was protective if taken in the pre-pregnancy trimester, it was less so when started during the first trimester of pregnancy, and other vitamins and Fe supplements without folk acid were not protective at any stage. This suggests the possibility of a real folic acid effect which was not due to analysis bias, as it is improbable that there would be substantial differences between women who take micronutrients containing folic acid and those who use similar preparations, but without the vitamin.
In the study of Mulinare et al. (1988) recall of self-administered vitamins was sometimes required over several years. This considerably weakens the power of the study, especially as pregnancy outcome was known, though not to the interviewer. However, recall bias was reduced by comparing vitamin use in NTD pregnancies with those where other malformations had occurred. The data were adjusted for known confounding variables which reduces analysis bias but, as the authors note, would not eliminate it. As with the study of Winship et al. (1984) the protective effect of vitamins was only found in the periconceptional period and not after the time of closure of the neural tube.
The study of Mills et al. ( 1 989) is similar to that of Mulinare et al. ( 1 988) but has reduced recall bias, the women being interviewed within 1 year of vitamin usage. No protective effect of vitamins was found . Mills et al. (1989) classified as non-takers those who started taking their vitamin supplements after conception. As another study suggests that vitamins started during early pregnancy, but before the time of neural tube closure, have a protective effect , this misclassification will tend to reduce any true difference between takers and non-takers.
Finally, in a similar study, but using women undergoing amniocentesis, a protective effect of folic acid, but not vitamins without folate, was found when the therapy was periconceptional (Milunsky et al. 1989) . The protective effect was lost when folic acid supplements were started more than 6 weeks after the end of the last monthly period. This study comes closest to eliminating the problems of bias as information about supplementation use was sought before the end of second trimester of pregnancy, and at this stage pregnancy outcome was largely unknown. Because the data were adjusted for confounding factors and, as in the study of Winship et al. (1984) , the effect was only seen with folate and not for vitamins without folate and then only if taken before the 6th week of pregnancy, the possibility of analysis bias producing the differences found is reduced.
Overall these studies indicate a protective effect of folk acid in early pregnancy. However, the report of Mills et al. (1989) , one of the two best studies, does not support this. A possible reason for this difference could be in the prevalence of NTD in the populations selected for study. Experience in Northern Ireland, an area of high prevalence, and southeast England, (relatively low), indicates that multi-vitamin supplementation has continued to be effective in reducing NTD recurrence in Northern Ireland, but is less effective in south-east England (Seller & Nevin, 1984; Nevin & Seller, 1990) . Table 5 shows that the prevalence rate for NTD in the retrospective study of Mills et al. (1989) is only half that of the other study areas and is close to the rate which suggests little environmental contribution to the prevalence of NTD (Janerich & Piper, 1978) . It is also relevant that in one of the studies (Mulinare et al. 1988 ) the protective effect of vitamin supplementation was only significant in whites, in whom the condition is known to be more prevalent than in blacks (Khoury et al. 1982) . This suggestion of an association between prevalence and success of treatment has implications for the prevention of NTD using multi-vitamins and for future randomized studies of periconceptional vitamin therapy. It may also provide clues to the aetiology of the condition.
P E R I C O N C E P T I O N A L V I T A M I N I N T E R V E N T I O N S T U D I E S I N P R O G R E S S
Although there is now a substantial amount of evidence suggesting a role for periconceptional vitamin supplements, especially folic acid, in the prevention of NTD, difficulties in interpreting many of the studies have encouraged researchers to begin randomized trials. We know of three such studies, two in women who are at risk of recurrence (Wald & Polani, 1984; Lenehan et al. 1988) and one study which is investigating prevention of first occurrence (Czeizel & Fritz, 1989) . Because NTD recurrences represent only a small minority of all NTD births, and because vitamin supplements have not yet been shown to prevent first occurrence, the study of Czeizel (Czeizel & Fritz, 1989 ) is of particular interest. The interim results of this study are consistent with a preventive role for periconceptional vitamin supplements (Czeizel & Fritz, 1989) . These studies are to be welcomed as they will almost certainly help to clarify the issue, but they may not resolve it completely. Since these programmes were started there has been an increase in folic acid consumption in women of child-bearing age in the United Kingdom due to fortification of certain breakfast cereals (J. Wild, personal communication). More directly, increased awareness in women at recurrence risk of the potential benefits offered by multi-vitamin therapy and the availability of multi-vitamin preparations from health food outlets may well encourage self-supplementation. Both these factors are likely to lead to an increase in folic acid supply to the fetus at the time of closure of the neural tube in women in all therapy arms of the randomized intervention studies.
We have already commented on the observation that success of periconceptional multivitamin supplementation seems to be directly associated with the prevalence of the condition. Prevalence has decreased in the United Kingdom during the last 15 years (Leck, 1983) . This, combined with the increased folic acid intake in early pregnancy, may reduce the differences in recurrence rates between placebo and active-therapy groups in current intervention studies even if vitamins have a role to play in the prevention of recurrence.
M I C R O N U T R I E N T METABOLISM A N D NTD
We have already indicated that NTD probably arises from an interaction between genetic and environmental factors, in which case it should be possible to consider the role of nutrients from both genetic and environmental aspects. On theoretical grounds, both could contribute to inadequate quantities of nutrients reaching the fetus. Diet could alter the supply and genetic factors the metabolism of nutrients, leading to reduced nutrient provision to the embryo, the two interacting to affect neural tube closure. There is experimental evidence for such an interaction, especially with regard to folic acid.
Maternal folic acid deficiency alone does not always cause NTD. Some studies have found an association between CNS malformations and severe folic deficiency while others have not (Fraser & Watt, 1964; Pritchard et al. 1970) . Subjects in these studies were investigated at term when folate status may not reflect the situation in early pregnancy. However, in our study of maternal nutrition in early pregnancy, although vitamin status on average was poorer in those who had an affected pregnancy (Table I) , a number of women with the lowest vitamin levels had normal babies (Smithells et al. 1976) . Conversely, periconceptional multi-vitamin supplementation as practised by us, although associated with a considerable decrease in NTD recurrence, does not always prevent it (Table 2) .
These findings are consistent with a defect of folic acid metabolism which is not severe enough to induce clinical problems in the mother but, when dietary supply is limited, could affect the fetus either because of the increased requirements of pregnancy (Schorah, 1988) , or because of a direct effect on transfer of vitamins to the fetus. Women who have had NTD affected pregnancies when supplemented with vitamins could have metabolic problems which are not responsive to supplementation or require supra-physiological doses of vitamins. The increased frequency of supplemented recurrences in low prevalence areas would then be accounted for by the fact that vitamin responsive women are already effectively treated by the better micronutrient nutrition present in these regions (Table 6 ; Tan et al. 1984) .
Is there any evidence for the existence of minor defects of folate metabolism in man? There are some indications that metabolic differences in folate handling exist between individuals in the general population, especially in pregnancy (Schorah, 1988) . Investigations of women at increased risk of NTD have shown evidence of disturbances in both folate and vitamin B,, metabolism. Abnormal N-formiminoglutamate excretion in women at the end of an NTD pregnancy, possibly reflecting deranged folate metabolism, was identified several decades ago (Hibbard & Smithells, 1965) . More recently, such women when not pregnant have been found to have lower erythrocyte folate levels than the general population: the greater the risk of NTD, the lower the mean erythrocyte folate Yates et al. 1987) . We have subsequently shown that the relatively close relationship between erythrocyte folate and dietary intake of the vitamin is lost in women who have had two previous NTD malformed fetuses and who are, therefore, at very high risk of recurrence (J. Wild, personal communication) . These investigations were undertaken in non-pregnant women, but women carrying an affected fetus have consistently shown lower erythrocyte folate levels (Smithells et al. 1976 ), but not decreased serum concentrations (Hall, 1972 (Hall, , 1977 Smithells et al. 1976; Molloy et al. 1985; Scott et al. 1990) . Taken together these findings suggest a metabolic disturbance primarily affecting the cellular folate pool.
We have recently been studying the folic acid metabolism of trophoblast cells grown in tissue culture. Overall uptake of radioactive labelled methyl-tetrahydrofolate and its incorporation into DNA is similar in tissue taken from normal and NTD affected pregnancies. However, the initial rate of uptake is much more rapid in trophoblasts cultured from normal than from affected pregnancies (Habibzadeh et al. 1990) (Table 7) .
Finally, raised levels of vitamin B,,-binding proteins (transcobalamins I and 11) have been reported in the amniotic fluid of pregnant women who have had previous NTD affected pregnancies (Magnus et al. 1986 ; Gardiki-Kouidou & Seller, 1988) . Disturbance of vitamin B,, metabolism could affect folic acid distribution because of the metabolic inter-relationships of the two vitamins (Scott & Weir, 1981) . All these studies suggest that the cell uptake of folk acid is affected in women at high risk for NTD or their fetuses. The studies on periconceptional vitamin supplementation support the concept that such metabolic disadvantages can be overcome by appropriate vitamin therapy in the majority of women with these lesions. The evidence is sufficient to support detailed investigation of folic acid metabolism in women at increased risk of NTD. The identification of metabolic abnormalities would make screening for such defects feasible. Vitamin prophylaxis could then be confined to this selected population as they reach child-bearing age.
CONCLUSIONS
We suggest that the accumulated evidence, particularly from the multi-vitamin intervention studies and the prospective studies published more recently in the USA, indicate that periconceptional multi-vitamin supplements, and folic acid in particular, can reduce the recurrence rate, and probably the prevalence, of NTD. We, therefore, recommend that the supplementation of women at risk of NTD recurrence should now become routine. This approach has most to offer in areas of high prevalence.
Although evidence suggests that folic acid deficiency is most closely linked to the causation of NTD, and this is biologically plausible because it is essential for DNA synthesis and cell division (Rolschau et al. 1979; Seller, 1983b) , we would at the present time, suggest supplementation with multi-vitamins at the recommended daily allowance for pregnancy, because this is the only therapy for which there is substantial evidence of safety and efficacy. In addition, good nutrition should always be encouraged, especially in women of child-bearing age, but this may be difficult to attain, especially among the disadvantaged in society, in whom NTD prevalence is highest.
In making such a recommendation we have considered the possibility of harmful effects of such treatment. There is evidence that vitamin A in doses greater than tenfold those provided by the supplement used in the vitamin intervention trials can be harmful in early pregnancy (Bernhardt & Dorsey, 1974; Stange et al. 1978; Rosa, 1983) . However, there are no reports of vitamins taken at the levels recommended for pregnancy causing harm. In over 1000 supplemented pregnancies in the intervention studies we have observed no excess of malformations and no disturbances of post-natal growth and development. However, trialists must continue to look for evidence of harm. This would be particularly relevant if treatment were to be extended to the general population among whom a much smaller proportion would stand to benefit from it.
It is important to begin vitamin treatment before the closure of the neural tube. Our overall experience suggests that, while 28 d of preconceptional supplementation achieves satisfactory blood vitamin levels , such early supplementation may not be essential . Starting supplements before the 20th day after conception may prove to be satisfactory, but we would advise caution here. We have seen a high NTD rate among a small number of women in whom supplements were started at times later calculated to be 2 7 4 1 d post-conception, that is after the usual time of closure of the neural tube ). We are aware of possible parallels here with the effect of vitamin A administration in the curly tail mouse, where the precise time of the administration determines whether the prevalence of NTD is reduced or increased (Seller, 1 9 8 3~) .
The recent findings of metabolic differences in handling of folate and vitamin B,, by women at increased risk of NTD should stimulate further research in this area. This could not only help to elucidate the causal mechanism, but could lead to the development of a screening test which would identify the metabolic lesion associated with liability to NTD and prevent unnecessary supplementation of very large numbers of women. During the preparation of this review, clarification of the role of vitamins in the prevention of NTD has come with the publication of the results of the UK Medical Research Council's study (MRC Vitamin Study Research Group, 1991) . In a randomised study, a significant (72 YO) reduction in NTD recurrence was achieved by periconceptional supplementation with folic acid, 4 mg/d, but not with other vitamins. These findings support the data presented in this review and underline many of the conclusions.
The smaller reduction in recurrence rate achieved in the MRC study (3-fold) compared with our own studies (7-fold) was predicted and the possible reasons for the difference considered (p. 41).
The choice between the folic acid doses used by the MRC (4mg) and by our group (0.36 mg) is not straightforward. For women with a family history of NTD, the higher dose may be appropriate (in practice 5 mg/d as 4 mg tablets are not commercially available), but this will only prevent NTD recurrences. For the prevention of first occurrences, a lower dose is more logical because it can be widely administered by fortification of staple foods, and because the risk of side-effects (e.g. nausea) with higher doses is avoided. However, it is possible that, because of the supporting role of a number of micronutrients in the metabolism of folic acid (Schorah, 1988) , the lower dose may not be as effective without the accompanying vitamins. The ongoing study of Lenehan et al. (1988) should resolve this issue as it includes a comparison of low dose folate with and without other vitamins.
Whether the causation of NTD includes an inborn error of metabolism which can be largely prevented by folk acid, or whether NTD is a newly-recognised symptom of dietary folate deficiency, remains to be determined. If the former, it is unusually common for an inherited metabolic defect: if the latter, dietary deficiency can occur with folate intakes achieved by most women on a typical UK diet.
Either way, we seem to have something new to medical science. This makes the continuing study of the precise role of folic acid in NTD important, not only for the reasons indicated in the conclusions to this review, but also because this may not be the only condition which can be modified by micronutrient intakes at the upper end of the usual range.
